Related Experiment Videos
Serological arguments for classifying Raynaud's phenomenon as idiopathic
A Gentric1, M A Blaschek, J F Le Noach
1Laboratory of Immunology, Brest University Medical School, France.
The Journal of Rheumatology
|September 1, 1990
Summary
This study analyzed autoantibodies in patients with idiopathic Raynaud
Area of Science:
- Rheumatology
- Immunology
- Internal Medicine
Background:
- Idiopathic Raynaud's phenomenon (IRP) diagnosis can be challenging.
- Autoantibodies may play a role in classifying IRP and predicting disease progression.
Purpose of the Study:
- To investigate the prevalence of various autoantibodies in patients with IRP.
- To determine if autoantibody profiles can aid in the accurate classification of IRP.
Main Methods:
- Prospective follow-up of 25 IRP patients for a mean of 48 months.
- Clinical and laboratory assessments, including sera analysis for autoantibodies (antinuclear, antiskeleton, antiorganelle).
Main Results:
- 16 patients were antinuclear antibody positive; 2 were anticentromere antibody positive.
- Prevalence of other antibodies: antivimentin (8), antimitochondrial (5), anti-Golgi complex (4), anticentriol (3), antidesmosome (11).
- Only one patient developed mixed connective tissue disease during follow-up.
Conclusions:
- Autoantibody screening may improve the accurate classification of idiopathic Raynaud's phenomenon.
- Identifying specific autoantibodies could refine IRP diagnosis and prognosis.